ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjögren’s syndrome"

  • Abstract Number: 0038 • ACR Convergence 2025

    DNA Methylation Signatures of Smoking in Labial Salivary Gland Tissue in a Sjögren’s Disease Cohort

    Priya Bhatt1, Mary Horton2, Caroline Shiboski3, Lisa Barcellos4 and Lindsey Criswell2, 1Mayo Clinic Alix School of Medicine, Toledo, 2NIH/NHGRI, Bethesda, MD, 3University of California San Francisco, San Francisco, CA, 4UC Berkeley, Berkeley

    Background/Purpose: Cigarette smoking has been linked to the development of several autoimmune diseases, including Sjögren’s Disease (SjD). Since DNA methylation (DNAm) is altered by cigarette…
  • Abstract Number: 2299 • ACR Convergence 2025

    Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive interstitial lung disease associated with primary sjögren’s syndrome

    Paula Estrada-Alarcón1, Delia Reina2, JUAN JOSE ALEGRE SANCHO3, Montserrat Roig Kim4, martí Aguilar-Coll5, Laia De Daniel Bisbe4, Aina Fabregat5, Monica Cubells5 and Javier Narváez6, 1Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 2Complex Hospitalari Universitari Moisès Broggi, Barcelona, Spain, 3Department of rheumatology. Hospital Universitario Doctor Peset, Valencia, Spain, 4Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, 5Hospital Universitari de Bellvitge, Barcelona, Spain, 6Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: To evaluate the real-world, long-term effectiveness of rituximab (RTX) as rescue therapy in patients with primary Sjögren’s syndrome-associated interstitial lung disease (pSS-ILD).Methods: Multicentre observational…
  • Abstract Number: 1951 • ACR Convergence 2025

    Quantitative HRCT Analysis in Sjögren’s Disease-associated ILD: CALIPER-Derived Imaging Biomarkers for Prognostic Assessment

    Gaetano La Rocca1, Francesco Ferro2, Vincenzo Uggenti3, Beatrice Dei4, Giovanni Fulvio4, Michele Moretti4, Marta Mosca5, Chiara Romei3 and Chiara Baldini5, 1University of Pisa, Rheumatology Unit, Pisa, Pisa, Italy, 2Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 3University of Pisa, 2nd Radiology Unit, Pisa, Italy, 4Rheumatology Unit, University of Pisa, Pisa, Toscana, Italy, 5University of Pisa, Pisa, Pisa, Italy

    Background/Purpose: Interstitial Lung Disease (ILD) is a frequent manifestation of Sjögren’s Disease (SjD), associated with significant morbidity and mortality. However, data on the prevalence of…
  • Abstract Number: 1400 • ACR Convergence 2025

    Beyond the Glands: Hypogammaglobulinemia as a Clue to Peripheral Neuropathy in Sjogren´s Disease

    Renata Fróes Ramos de Lima1, Regis Sewa Marques2, Zoraida Sachetto3 and Alisson Pugliesi4, 1Universidade Estadual de Campinas (UNICAMP), Campinas, Sao Paulo, Brazil, 2Universidade Estadual de Campinas, Campinas, Sao Paulo, Brazil, 3UNIVERSIDADE ESTADUAL DE CAMPINAS, UNICAMP, Campinas, Sao Paulo, Brazil, 4Unicamp, Campinas, Brazil

    Background/Purpose: Sjogren’s disease (SjD) is a systemic autoimmune disorder characterized by inflammatory involvement of the exocrine glands and extra-glandular manifestations. Among the latter, there is…
  • Abstract Number: 1383 • ACR Convergence 2025

    Obesity in Primary Sjogren’s Disease

    Gabriela Hernandez-Molina1, Donaji Gómez-Velasco2, Ariel Garcia-Torralba2, Carlos Aguilar-Salinas2 and Ivette Cruz-Bautista2, 1Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Federal District, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: Obesity is an excessive fat accumulation that presents a risk to health. Little is known about the relationship between obesity and Sjögren’s disease (SjD).…
  • Abstract Number: 0520 • ACR Convergence 2025

    Implementation of Salivary Gland Ultrasound by General Radiology can Improve Detection of Glandular Inflammation in Patients with Sicca

    Stephanie Lee1, Chadwick Johr2, Nora Sandorfi2, Ali Dhanaliwala2 and Dana DiRenzo2, 1University of Pennsylvania & Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Salivary Gland Ultrasound (SGUS) can be useful in the evaluation and management of Sjögren’s Disease (SjD) but its use has been limited to trained…
  • Abstract Number: 0019 • ACR Convergence 2025

    Single cell characterization of the circulating immune system in Sjögren’s Syndrome

    Alejandro Gómez Gómez1, Héctor Corominas2, Rosario Garcia Vicuña3, Mercedes Freire González4, Sheila Melchor-Díaz5, Paloma Vela Casasempere6, Paula Estrada-Alarcón7, Jose Luis Tandaipan8, Monica Fernandez Castro9, Sara Maria Rojas Herrera10, Marina Rodríguez López11, Beatriz Paredes-Romero12, Santiago Muñoz13, Marta López14, Ignacio Braña15, Gema Bonilla16, Raúl Menor Almagro17, Sara Manrique-Arija18, Mª Angeles Blazquez Cañamero19, Lilian López-Núñez20, Carles Galisteo Veiga21, Juan José Alegre-Sancho22, Jose Rosas Gómez de Salazar23, Jose Javier Pérez Venegas24, Judit Font-Urgelles25, José Andrés Román Ivorra26, José Miguel Sequí-Sabater27, Rafaela Ortega-Castro28, Clara Moriano29, Guadalupe Manzano-Canabal30, Cilia Peralta-Ginés31, Javier Narváez32, Rafael Cáliz-Cáliz33, Javier Martínez-Ferrin34, Lara Sánchez Bilbao35, Belén Serrano-Benavente36, Natalia Boix- Martí37, Ares Selles-Rius38, Maribel Pérez39, Juan Cañete40, Núria Palau Balaña38, Damiana Alvarez Errico39, Yolanda Guillén41, Juan Ángel Patiño Galindo41, Antonio Julià1, Sara Marsal Barril42 and Jose Luis Andreu43, 1Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain, 2Hospital de la Santa Creu i Sant Pau, Rheumatology, Barcelona, Barcelona, Spain, 3Hospital Universitario de la Princesa, Madrid, Spain, 44 Hospital Universitario A Coruña, Rheumatology, A Coruña, La coruna, Spain, 5Hospital Universitario 12 de Octubre, Rheumatology, Madrid, Madrid, 6Hospital General Universitario Alicante, Alicante, Comunidad Valenciana, Spain, 7Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 8Rheumatology. Hospital Universitario de la Santa Creu i Sant Pau, Barcelona, Spain, 9PUERTA DE HIERRO HOSPITAL, Madrid, Spain, 10Hospital de Mérida, Rheumatology, Badajoz, Badajoz, Spain, 11Complejo Hospitalario Universitario de Santiago, Rheumatology, Santiago de Compostela., Santiago de Compostela, Spain, 12Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, San Sebastian de los Reyes, Spain, 13Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, Madrid, Spain, 14Complex Hospitalari Universitari Moisés Broggi, Barcelona, Spain, 15Hospital Universitario Central de Asturias, Oviedo, Spain, 16Hospital Universitario La Paz, Rheumatology, Madrid, Madrid, Spain, 17Department of Rheumatology, Hospital de Jerez, Spain, Puerto De Santa María, Spain, 18Hospital Regional Universitario Málaga, Malaga, Spain, 19Hospital Ramon y Cajal, Madrid, Spain, 20Hospital Son Llatzer, Rheumatology, Palma de Mallorca, Palma de Mallorca, Spain, 21Hospital Parc Taulí, Rheumatology, Sabadell, Sabadell, Spain, 22Hospital Universitario Doctor Peset, Valencia, Spain, 23Hospital Marina Baixa, PALMA DE MALLORCA, Spain, 24Virgen Macarena University Hospital, Sevilla, Spain, Sevilla, Spain, 25Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 26Hospital Universitari i Politècnic La Fe, Valencia, Spain, 27Hospital Universitario La Fe (Valencia), Valencia, Spain, 28Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Andalucia, Spain, 29Hospital León, LEON, Castilla y Leon, Spain, 30Hospital Virgen de la Concha (Zamora), Zamora, Spain, 31Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 32Hospital Universitario de Bellvitge, Barcelona, Spain, 33Hospital Universitario Virgen de las Nieves, Rheumatology, Granada, Granada, Spain, 34Hospital Universitario Virgen de la Arrixaca, Rheumatology, Murcia, Murcia, Spain, 35Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 36Hospital Gregorio Marañon, Madrid, Spain, 37Hospital Univetsitari Vall d'Hebron, Rheumatology Department, Barcelona, Spain, 38Rheumatology Research Group, Vall d'Hebron University Hospital, Barcelona, Spain, 39IMIDomics, Barcelona, Barcelona, Spain, 40Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona, Spain, Barcelona, Spain, 41IMIDomics, Barcelona, Spain, 42Vall Hebron Hospital Research Institute, Barcelona, Spain, 43Hospital Universitario Puerta de Hierro, Majadahonda, Spain

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by the infiltration of circulating immune cells into the salivary and lacrimal glands. The properties…
  • Abstract Number: 2297 • ACR Convergence 2025

    Clinically Relevant Anti-Vaccine and Virus Antibodies in Patients with Sjogren’s Disease Treated with Nipocalimab: Post-Hoc Analysis of the DAHLIAS Study

    Faye Yu1, Eugene Myshkin1, Jonathan J. Hubbard2, Kim Campbell2, Matthew Loza3, Dessislava Dimitrova2, Carolyn Cuff1 and Sheng Gao3, 1Johnson & Johnson, Cambridge, MA, USA, Cambridge, MA, 2Johnson & Johnson, Spring House, PA, USA, Spring House, PA, 3Johnson & Johnson, Spring House, PA

    Background/Purpose: Nipocalimab is a fully human, high affinity, aglycosylated, effectorless IgG1 monoclonal antibody designed to selectively block neonatal fragment crystallizable receptor (FcRn), thereby lowering serum…
  • Abstract Number: 1939 • ACR Convergence 2025

    Salivary Gland Ultrasounds Can Be Read by General Radiologists: A Review Of 4 Years of Reports from an Urban Academic Radiology Department

    Ali Dhanaliwala and Dana DiRenzo, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Salivary gland ultrasound (SGUS) has the potential to inform diagnosis and progression of Sjogren’s disease, a systemic autoimmune disease which results in progressive inflammation…
  • Abstract Number: 1399 • ACR Convergence 2025

    Significance of Antiphospholipid Antibodies in Patients with Sjogren’s Disease

    Rashmi Thimmapuram1, Ahmad Alkhatib2, Joshua Baker3, Mehrdad Maz4 and Ghaith Noaiseh2, 1University of Kansas Medical Center, Westwood, KS, 2University of Kansas Medical Center, Kansas City, KS, 3University of Pennsylvania, Philadelphia, PA, 4The University of Kansas Medical Center, Kansas City, KS

    Background/Purpose: A few reports have evaluated the frequency of antiphospholipid antibodies (aPL) in Sjogren’s disease (SjD) and their association with SjD or Antiphospholipid Antibody Syndrome…
  • Abstract Number: 1382 • ACR Convergence 2025

    Interstitial lung disease in primary sjögren syndrome: pathochrony, seronegative cases, and Risk of progressive pulmonary fibrosis

    Delia Reina1, Paula Estrada-Alarcón2, Daniel Roig-Vilaseca1, Dacia Cerdà1, Vanessa Navarro-Angeles3, oscar Camacho1, Sergi Herdia4, Marta lópez-Gómez1, Silvia Gacía-Díaz1, Paola Vidal Montal5, Pol Maymó-Paituvi6, martí Aguilar-Coll7 and Javier Narváez8, 1Complex Hospitalari Universitari Moisès Broggi, Barcelona, Spain, 2Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 3Department of Rheumatology, Complex Universitari Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain, Sant Joan Despí, Barcelona, Spain, 4Complex Hospitalari Moisès Broggi, Barcelona, Spain, 5Bellvitge University Hospital, Barcelona, Spain, 6Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, 7Hospital Universitari de Bellvitge, Barcelona, Spain, 8Hospital Universitari de Bellvitge, L'Hospitalet; Barcelona, Barcelona, Spain

    Background/Purpose: Sjögren’s disease (SjD) is a chronic autoimmune disorder primarily targeting exocrine glands. A significant extraglandular manifestation is interstitial lung disease (ILD), which contributes to…
  • Abstract Number: 0518 • ACR Convergence 2025

    Deregulation of PSGL-1, HLA-DR and IFNα expression in peripheral innate immune cells of primary Sjögren Syndrome patients

    Santos Castañeda1, Alejandra Ramos-Manzano2, Ines Sanchez-Abad3, Miren Uriarte-Ecenarro4, M. Paula Alvarez-Hernandez4, Esther San-Antonio4, Esther Vicente-Rabaneda5 and Ana Urzainqui4, 1Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Madrid, Spain, 2Hospital Unversitario de la Princesa, Madrid, Madrid, Spain, 3Hospitla de la Princesa, Madrid, Spain, 4Hospital de la Princesa, Madrid, Madrid, Spain, 5Hospital Universitario de La Princesa, Madrid, Spain

    Background/Purpose: Primary Sjögren's Syndrome (pSS) is an autoimmune disease characterized by lymphocytic infiltration of exocrine glands and systemic manifestations including cutaneous and renal involvement. Phagocytes--monocytes,…
  • Abstract Number: 2298 • ACR Convergence 2025

    When Imaging and Biopsy Disagree: Diagnostic Value of Doppler Ultrasound and Histologic Features beyond the Focus Score

    kyung-Ann Lee1, Yeonhee Kim1, Se Hee Kim2 and Hyun-Sook Kim3, 1Soonchunhyang University Hospital Seoul: Soonchunhyang University Hospital, Seoul, Republic of Korea, 2Kyung Hee University College of Medicine, Seoul, Republic of Korea, 3Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea

    Background/Purpose: Salivary gland ultrasound (SGUS) and minor salivary gland biopsy (MSGB) are widely used in the diagnosis of primary Sjögren’s syndrome (pSS). However, discordance between…
  • Abstract Number: 1881 • ACR Convergence 2025

    Silent Impact: Two Decades of Sjögren’s Syndrome Mortality in the United States

    Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, MD Walid Akram Hussain2, Reshma John2, Elvira Assaf2, Amer Al Badawy2, Barbare Khatiashvili2, Rouba Isshak2, John Salama2, Ibrahim Sabah2 and Robert Lahita3, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3St. Josephs University Medical Center, Wayne, NJ

    Background/Purpose: Sjögren’s syndrome is a chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands with potential systemic involvement. Despite its known complications, population-level mortality…
  • Abstract Number: 1398 • ACR Convergence 2025

    Reproductive Challenges and Cardiovascular Risks in Sjögren’s Syndrome and Systemic Sclerosis: A Meta-Analysis of Fertility, Pregnancy Outcomes, and Maternal Cardiac Health

    R. Mohamad Javier1, Bernadus Bramantyo2, Arkan Berlian3, Mahardika Nugraha4, Azzura Simanulang1, Eko Setyo Herwanto5, Athaya Febriantyo Purnomo6, Jonathan Jonathan7, Ananingati Ananingati5, Budi Prakoso8 and Aisyah Rizki Nirmala Hanum5, 1University of Indonesia Hospital, Jakarta Selatan, Jakarta Raya, Indonesia, 2Sardjito General Hospital, Daerah Istimewa Yogyakarta, Yogyakarta, Indonesia, 3Dr. Cipto Mangunkusumo Hospital, Jakarta Barat, Jakarta Raya, Indonesia, 4Universitas Islam Sultan Agung, KOTA SEMARANG, Jawa Tengah, Indonesia, 5Universitas Muhammadiyah Malang, Malang, Jawa Timur, Indonesia, 6Saiful Anwar General Hospita, Malang, Jawa Timur, Indonesia, 7RSUD Kalideres, Jakarta, Jakarta Raya, Indonesia, 8Department of Internal Medicine, RST dr Soepraoen, Malang, Jawa Timur, Indonesia

    Background/Purpose: Autoimmune rheumatic diseases such as Sjögren’s Syndrome (SS) and Systemic Sclerosis (SSc) can significantly impact reproductive health and increase maternal cardiovascular risk. These conditions…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology